Walgreens is offloading more shares in drug distributor Cencora as the struggling pharmacy chain looks to generate cash. The latest sale netted about $300 million for Walgreens, and shrinks the ...

Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt paydown and general corporate purposes,” the company said ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount ...

Cencora (COR) has significantly expanded the number and type of medications available in its sure supply program, a drug shortage mitigation initiative designed to provide health systems with ...

Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in ...

Marks significant expansion of initiative to help health systems access critical, at-risk medications for patients CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global healthcare company, has ...

Hello and welcome everyone to the Cencora Q1 fiscal year 2025 earnings ... income headwind in the second quarter of fiscal 2025, meaning no significant expected contribution from COVID vaccines ...

Mauch emphasized the strategic alignment of the RCA acquisition with Cencora’s pharmaceutical-centric strategy. CFO James Cleary noted, "Cencora delivered strong results in the first quarter ...

CONSHOHOCKEN, Pa. (AP) — CONSHOHOCKEN, Pa. (AP) — Cencora, Inc. (COR) on Wednesday reported fiscal first-quarter net income of $488.6 million. The Conshohocken, Pennsylvania-based company said ...

Cencora's Q1 sales rose 12.8% to $81.5B, surpassing the estimate, driven by GLP-1 drug sales and specialty product growth. Adjusted EPS grew 13.7% to $3.73, topping the consensus. FY25 EPS outlook ...